(Q33388853)

English

Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study.

scientific article

Statements

Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study. (English)
0 references
0 references
0 references
Anjali Advani
Bertrand Coiffier
Myron S Czuczman
Martin Dreyling
Christian Gisselbrecht
Nicolas Ketterer
Sunita Nasta
Ama Rohatiner
Ingo G H Schmidt-Wolf
Martin Schuler
Jorge Sierra
Jane N Winter
Joseph Boni
Erik Vandendries
Mark Shapiro
2085-2093

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit